Combination of nusinersen and rehabilitation using hybrid assistive limb for type 3 spinal muscular atrophy

Documenti analoghi

• Bulbar function in children with spinal muscular atrophy type 1 treated with nusinersen
  di: Georgia Stimpson, et al.
  Pubblicazione: (2025)
• Analysis of the efficacy and adverse effects of nusinersen in the treatment of children with spinal muscular atrophy in China
  di: Dan Li, et al.
  Pubblicazione: (2024)
• Safety of risdiplam in spinal muscular atrophy patients after short‐term treatment with nusinersen
  di: Yue Yan, et al.
  Pubblicazione: (2024)
• Ultrasound‐assisted and landmark‐based nusinersen delivery in spinal muscular atrophy adults: A retrospective analysis
  di: Bruno Antonio Zanfini, et al.
  Pubblicazione: (2024)
• Six‐minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen
  di: Alessandra Govoni, et al.
  Pubblicazione: (2024)